Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking approach to diabetes management. These innovative therapies function by mimicking the inherent actions of GLP-1, a hormone released by the https://haimaequd028024.post-blogs.com/59698579/the-emerging-role-of-glp-1-receptor-agonists-in-diabetes-management